https://www.selleckchem.com/pr....oducts/larotrectinib
d efficient ways of restructuring an outpatient clinic.BACKGROUND Renal replacement therapy was a lifesaving yet high-cost treatment for people with end-stage kidney disease (ESKD). This study aimed to estimate the direct medical costs per capita of ESKD by different treatment strategies haemodialysis (HD); peritoneal dialysis (PD); kidney transplantation (KT) (in the first year); KT (in the second year), and by two urban health insurance schemes. METHODS This was a retrospective observational cohort study. Data were obtained from